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Chylomicron remnants (CMRs) contribute directly to human monocyte activation in vitro, by increasing reactive oxygen species
(ROS) production and cell migration. In this study, the eﬀects of the oxidative state of CMR on the degree of monocyte activation
was investigated. CMR-like particles (CRLPs) were prepared in three diﬀerent oxidative states, normal (CRLPs), protected from
oxidation by incorporation of the antioxidant, probucol (pCRLPs), or oxidised with CuSO4 (oxCRLPs). Lipid accumulation and
ROS production were signiﬁcantly increased in primary human monocytes incubated with CRLPs, whilst secretion on monocyte
chemoattractant protein-1 was reduced, but oxCRLPs had no additional eﬀect. In contrast, pCRLPs were taken up by monocytes
to a lesser extent and had no signiﬁcant eﬀect on ROS or MCP-1 secretion. These studies suggest that the oxidative state of CMRs
modulates their stimulation of the activation of peripheral blood human monocytes and that dietary antioxidants may provide
some protection against these atherogenic eﬀects.
1.Introduction
It is now acknowledged that cardiovascular disease (CVD)
is the largest killer in western countries [1]. Atherosclerosis
is major cause of CVD, and it has become clear in the past
decades that it is a chronic inﬂammatory disease [2]. Ac-
tivation of monocytes is an early event in atherogenesis, trig-
gering their adhesion to the endothelium, migration into the
arterial intima, and diﬀerentiation into macrophages [3–5].
The role of low-density lipoprotein (LDL) in early ather-
ogenesis is also well understood, it accumulates in the de-
veloping neointima where it is taken up by macrophages
to form foam cells, leading to fatty streak formation, and
these eﬀects are greatly enhanced after oxidation of the
particles. Oxidized LDL (oxLDL) also stimulates secretion of
proinﬂammatory cytokines, chemokines, and other factors
by macrophages, which exacerbates endothelial dysfunction
and drives lesion progression [6]. In recent years, however,
evidence has accumulated to indicate that lipoproteins of
dietary origin are also atherogenic [7, 8].
Lipids from the diet are absorbed in the gut and secreted
into lymph in large, triacylglycerol- (TG-) rich lipoproteins
called chylomicrons. They pass through the thoracic duct
and into the blood where they undergo rapid lipolysis, losing
some of their TG to form smaller chylomicron remnants
(CMRs), which then deliver the remaining TG, cholesterol,
and other lipids to the liver. CMRs have been shown to
enter the artery wall as eﬃciently as LDL and to be retained
in the intima [9–11], and particles resembling CMRs have
been isolated from the neointima of human atherosclerotic
plaques and in animal models of atherosclerosis [12, 13].
Moreover, delayed clearance of CMRs from the blood cor-
relates with the development of atherosclerotic lesions and is
associated with consumption of western diets, obesity, and
type 2 diabetes [14].2 International Journal of Vascular Medicine
We and others have shown previously that CMRs are
taken up and induce foam cell formation in human mon-
ocyte-derived macrophages (HMDMs) [15, 16], in macro-
phages derived from the human monocyte cell line THP-1
[16–18], and in the murine macrophage cell line J774 [19]
and that this leads to modulation of the expression of genes
involved in lipid metabolism [20]. Furthermore, we have
also found that these lipoproteins inﬂuence the secretion
of proinﬂammatory chemokines and cytokines by HMDM
andTHP-1macrophagesviaregulationatthetranscriptional
level [21, 22].
Unlike LDL, CMRs are able to induce their eﬀects on
macrophage foam cell formation and on proinﬂammatory
cytokine secretion without prior oxidation [16–22]. How-
ever, our earlier work has demonstrated that, in striking
contrast to the eﬀects of LDL oxidation, the oxidative state
of CMRs is inversely related to their ability to induce foam
cell formation. Thus, when CMRs are protected from oxi-
dation by incorporation of antioxidants into the particles,
lipid accumulation in macrophages is increased [17, 23],
while oxidation of CMRs inhibits their ability to induce
foam cell formation [18, 24]. Our studies have also shown
that the oxidative state of CMRs plays an important role
in their eﬀects on proinﬂammatory cytokine secretion by
macrophages [22].
Since monocytes are the precursors of macrophage foam
cells, the processes which activate them and cause their
recruitment to the artery wall are crucial early events in
atherogenesis.Activationofmonocytesduringinﬂammation
involves increased secretion of chemokines and cytokines
and other vasoactive mediators together with the production
of reactive oxygen species (ROS) [25–27], and recent work
has suggested that CMRs may inﬂuence some of these
processes. Castro Cabezas and colleagues have reported that
expression of adhesion molecules is upregulated in leuko-
cytes after a fat meal [28, 29], and studies in our laboratory
have shown that CMRs are taken up by both primary human
monocytes and THP-1 monocytes, causing ROS production,
modulation of chemokine and cytokine secretion, and
altered chemotaxis [30]. The importance of the oxidative
state of CMR in their eﬀects on monocyte activation, how-
ever, are not known.
Oxidation of CMR by the lipoxygenase and myeloper-
oxidase enzymes which are known to oxidize LDL is likely
to occur when the particles enter and are retained in the
artery wall. In addition, oxidized lipids resulting from the
consumption of fat cooked at high temperatures as well as
dietary lipophilic antioxidants are carried in the blood in
CMR [31, 32]. It is important, therefore, to establish how
the oxidative state of the particles may inﬂuence their eﬀects
on the early stages of atherogenesis. The aim of this study
was to determine whether the oxidative state of CMRs in-
ﬂuences their uptake by monocytes and subsequent pro-
inﬂammatory pathways, using primary human monocytes
and model chylomicron remnant-like particles (CRLPs).
2.MaterialsandMethods
All chemicals and tissue culture reagents were from Sigma
(Poole, Dorset, UK) unless otherwise stated. Tissue culture
plastics from Falcon Discovery Labware range (Fisher Scien-
tiﬁc, UK) were used.
2.1.PreparationofCRLPs. CRLPswerepreparedasdescribed
previously [16]. Brieﬂy, a lipid mixture containing 70%
trilinolein, 2% cholesterol, 3% cholesteryl ester, and 25%
phospholipids in 0.9% NaCl (w/v) in Tricine Buﬀer (20mM,
pH 7.4) was sonicated in 22–24μmf o r2 0 m i na t5 6 ◦C,
followed by ultracentrifugation on a stepwise density gra-
dient at 17,000×g. To bind ApoE, lipid particles were col-
lected from the top layer after ultracentrifugation and in-
cubated with the d 1.063–1.21g/mL fraction of human
plasma (National Blood Transfusion Service, North London
Centre, UK) which had previously been dialysed (18h, 4◦C).
ApoE-containing-CRLPs were then isolated by two further
ultracentrifugation steps in d 1.006g/mL at 120,000×g,
12h, 4◦C, followed by 202,000×g, 4h, 4◦C, and stored at
4◦C under argon until required. All preparations were used
within one week. To prepare probucol-containing CRLPs
(pCRLPs),1mgprobucolwasaddedtolipidmixturepriorto
sonication. CRLPs were oxidized (oxCRLPs) by incubation
with CuSO4 (20μM) with shaking for 5h at 37◦C followed
by dialysis to remove the CuSO4 (0.9% NaCl, 24h, 4◦C).
Controlpreparations,obtainedbyasimilarproceduretothat
described for CRLPs, but in the absence of the lipid particles,
were included in all experiments to control for possible con-
tamination factors originating from plasma. Data obtained
from monocytes incubated with control preparations were
similar to those derived from cells incubated in medium
alone.
2.2. Isolation of Human Peripheral Blood Monocytes. With
approval from the East London Research Ethics Committee,
blood was taken by venepuncture from healthy volunteers
into 15% EDTA tubes. Monocytes were isolated by negative
selection using RosetteSep according to the manufacturer’s
instructions (StemCell Technologies, London, UK). Cells
were resuspended in RPMI containing 2mM L-glutamine,
10,000units/mL Penicillin, 10mg/mL streptomycin, and
10% (v/v) fetal bovine serum (PAA, Somerset, UK). Mono-
cyte preparations were routinely stained with anti-CD14
antibody (Becton Dickinson, Oxford, UK) followed by ﬂow
cytometric analysis to verify purity.
2.3. Oil Red O Staining. 1 × 106 monocytes were incubated
with CRLPs (15μgo r3 0 μgcholesterol/mL) (or a similar
volume of control preparation) and incubated at 37◦Cf o r
24h. Cells were adhered to microscope slides by cytospin
(Shandon, ThermoFisher Basingstoke, UK) and stained with
OilR edOasdescribedpreviously[16].Imageswerecaptured
using a Leica upright DM4000B brightﬁeld microscope
(Leica Microsystems GmbH; Wetzlar, Germany) and the ex-
tent of staining analyzed using Volocity (Perkin Elmer,
Beaconsﬁeld, UK).
2.4. Measurement of Reactive Oxygen Species (ROS). Mono-
cytes were loaded with dihydrorhodamine-1, 2, 3 (ﬁnal
concentration 100μM) for 10min at room temperature andInternational Journal of Vascular Medicine 3
seeded onto white opaque 96-well tissue culture plates (2.5×
104 labelled monocytes/well). CRLPs, oxCRLPs or pCRLPs
containing 7.5μg/mL, 15μg/mL, or 30μg/mL cholesterol or
a similar volume of control preparation were added, and
plates were incubated at 37◦C for up to 2h in 5% CO2.
Fluorescence was measured using a Wallac1410 ﬂuorescent
microtitre plate reader (Perkin Elmer, Beaconsﬁeld, UK) at
0, 5, 10, 15, 30, and 60min.
2.5. Measurement of Chemokine Secretion. Monocytes were
seeded at 5 × 105 cells/well in 24-well tissue culture plates,
CRLPs, oxCRLPs or pCRLPs containing 15μg/mL, 30μg/mL
cholesterol or a similar volume of control preparation were
added and plates were incubated at 37◦C/5% CO2 for 24h.
Cells were pelleted and the supernatants collected, snap
frozen, and stored at −80◦C until analysis of MCP-1 secre-
tion using ELISA Duoset assay kits according to the man-
ufacturer’s instructions (R&D Systems, Oxford, UK).
2.6. Other Analytical Methods. The total cholesterol and tria-
cylglycerol (TG) content of CRLPs was determined by enzy-
matic analyses (Thermo Fisher Scientiﬁc, Waltham, UK).
Thelevelofthiobarbituricacid-reactingsubstances(TBARS)
[33] in the CRLP preparations was used to determine the
extent of oxidation of the particles.
2.7. Statistical Analysis. Statistical analysis was carried out
using Prism (Graphpad, USA). One-way ANOVA followed
by Bonferroni’s comparison test was used as appropriate. To
analyse diﬀerences in ROS production, area under curves
(AUCs) were calculated with Prism and compared by Stu-
dent’s t-test. P<0.05 was considered statistically signiﬁcant.
All experiments were repeated with at least three separate
monocyte isolates and two separate CRLP preparations.
3. Results andDiscussion
3.1. Results
3.1.1.CharacteristicsofCRLPs. ThelipidandTBARScontent
of CRLPs, oxCRLPs, and pCRLPs is shown in Table 1.
There were no signiﬁcant diﬀerences in the TG and total
cholesterol concentration of the three CRLP types and the
TG:TC molar ratio. More importantly, the TG:TC ratio
was not signiﬁcantly diﬀerent among the three CRLP types.
Signiﬁcantdiﬀerencesin theTBARSand lipid hydroperoxide
content of the CRLPs in diﬀerent oxidative states were ap-
parent,withthevaluesforoxCRLPsbeingsigniﬁcantlyraised
and those for pCRLPs signiﬁcantly decreased as compared to
those for CRLPs.
3.1.2. Lipid Accumulation in Primary Human Monocytes aft-
er Incubation with CRLP, pCRLP, or oxCRLP. After 24h
incubation, Oil Red O staining for lipid was increased in
monocytes coincubated with CRLPs or oxCRLPs, at a con-
centration of 15μg/mL cholesterol (Figure 1(a)), and quan-
titative analysis of the staining density showed that the
Table 1: Lipids and TBARS content of CRLP.
Parameter CRLPs oxCRLPs pCRLPs
TG (μmol/mL) 9.44 ±2.33 6.01 ±1.31 7.82 ±1.50
TC (μmol/mL) 0.98 ±0.24 0.61 ±0.18 1.03 ±0.21
TG:TC (molar ratio) 10.1 ±1.61 2 .7 ±3.17 .5 ±0.9
TBARS (nmol
MDA/μmol TG) 0.78 ±0.05 4.00 ±0.90∗∗ 0.39 ±0.15∗∗
CRLPs,oxCRLPsorpCRLPswerepreparedasdescribedinSection 2andthe
TG, total cholesterol (TC) and TBARS content was measured. Data are the
mean 4 preparations. Signiﬁcance limits; ∗∗P<0.01 versus CRLP.
changes were highly signiﬁcant in comparison to control
cells (Figure 1(b)). Uptake also appeared to be increased
after incubation with the higher concentration of CRLP or
oxCRLP (30μgcholesterol/mL); however, in this case the
changes did not reach statistical signiﬁcance. There were
no signiﬁcant diﬀerences in staining density between the 15
and30μgcholesterol/mLconcentrationsforanyoftheCRLP
types. In contrast, after coincubation of monocytes with
pCRLPs there was no visible increase in lipid accumulation
above cultures treated with control preparations, and this
was conﬁrmed by staining density analysis (Figure 1(b)).
3.1.3. Reactive Oxygen Species Generation after Incubation of
Primary Human Monocytes with CRLP. To determine the
eﬀects of CRLP in diﬀerent oxidative states on ROS accumu-
lation in monocytes (Figure 2), ﬂuorescence was measured
at time points between 0 and 60min after the addition of
CRLPs, oxCRLPs, or pCRLPs to the medium (Figures 2(a)–
2(c)) and the area under curve (AUC) was calculated for
each experiment (Figures 2(d) and 2(e)). Addition of CRLPs
or oxCRLPs led to higher ROS production as assessed by
the AUC when compared to incubation with the control
preparation (Figures 2(e) and 2(f)), and the changes were
signiﬁcant at concentrations of 15 and 30μgcholesterol/mL
(Figures 2(e) and 2(f)). After incubation with pCRLP; how-
ever, there was no increase in ROS generation in comparison
to control cells at any concentration of cholesterol (Figures
2(e) and 2(f)).
3.1.4. MCP-1 Production by Primary Human Monocytes after
Incubation with CRLP. After incubation of monocytes with
CRLP or oxCRLP (15 or 30μgcholesterol/mL) there was
a decrease in MCP-1 secretion compared to control cells
(Figure 3), and this eﬀect reached signiﬁcance at a concen-
tration of 30μgcholesterol/mL (Figure 3(b)). Incubation of
monocytes with pCRLP at similar concentrations, on the
other hand, had no signiﬁcant eﬀect on MCP-1 secretion
(Figure 3).
3.2. Discussion. There is increasing evidence from recent in
vitro and in vivo h u m a ns t u d i e si no u rl a b o r a t o r ya n d
others to indicate that interaction of CMRs with monocytes
may contribute to atherosclerosis progression. Postprandial
analysis of human leukocytes isolated after ingestion of a
fat meal revealed that they take up TG-rich lipoproteins,4 International Journal of Vascular Medicine
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Figure 1: Uptake of native, oxidised, and probucol treated CRLP by primary human blood monocytes. Monocytes were incubated with
CRLP at 37◦C for 24h before cytospin ﬁxation and oil Red O staining. (a) Representative images (captured at magniﬁcation ×40 and
enlarged). (b) Volocity quantitation (pixel count analysis) from n = 6 monocyte isolations. Approximately, 700 cells were examined for
each condition. C15/C30 control equivalent volume to 15/30μg/mL cholesterol, N15/N30, CRLP at 15/30μg/mL cholesterol, O15/O30
oxCRLP at 15/30μg/mL cholesterol, P15/P30 pCRLP at 15/30μg/mL cholesterol. ∗∗P<0.01, ∗∗∗P<0.001 analysis by one-way ANOVA and
Bonferroni’s posttest.
resulting in increased expression of activation markers in-
cluding CD11b [28]. In addition, our previous work has
demonstrated that chylomicron remnants inﬂuence proin-
ﬂammatory, pro-atherogenic signalling in human primary
monocytes including ROS production, cytokine and che-
mokine expression, as well as modulating their migration
towards a chemotactic gradient [30]. This is likely to be sig-
niﬁcant for development of atherosclerosis, taken together
with the ﬁnding that removal of CMR from the blood is
delayed in several common conditions such as obesity and
type 2 diabetes [34].
The oxidative state of CMR may be inﬂuenced by a
number of factors. They may be protected from oxidation
by the presence of lipophilic antioxidants from the diet,
they are known to carry oxidized lipids from the diet and
it seems likely that they are also oxidized within the artery
wall by the processes which are known to cause LDL
oxidation [31, 32, 35], and the relatively large and potentially
polyunsaturated fatty acid-rich CMRs particles are thought
to deliver a greater oxidant load to the artery wall than
LDL [36]. Furthermore, our earlier work has established
that the oxidative state of CMR has profound eﬀects
on their interactions with macrophages [18, 22, 24]a n d
thus is important for their potential atherogenicity. In the
present study, we have investigated the importance of the
oxidative state of CRLP on monocyte lipid accumulation
and activation. The model CRLPs used have been shown
to resemble physiological CMR in their size, density, and
lipid composition and to be metabolised in a similar way
both in vivo and in vitro in cell cultures [16, 19, 37–
40]. Moreover, the maximum concentration of CRLP used
(30μgcholesterol/mL (78μM)) is well within the range
found in triglyceride-rich lipoproteins (TRL) in human
plasma (postprandially; TRL cholesterol values have been
reported to reach 180–250μM[ 41, 42]).
Our previous ﬁndings with macrophages using both
HMDM and THP-1 macrophages have demonstrated that
the eﬀects of CRLPs on lipid accumulation are inversely
related to their oxidative state of the particles [17, 18, 22].
In contrast, in primary human monocytes, CRLPs protected
from oxidation by the incorporation of probucol were found
to inhibit intracellular lipid accumulation (Figure 1), whilstInternational Journal of Vascular Medicine 5
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Figure 2: Generation of reactive oxygen species after coculture of CRLP with primary human blood monocytes. Monocytes were preloaded
with dihydrorhodamine 1, 2, 3 before incubation with CRLPs, oxCRLPs, or pCRLPs and measurement of ﬂuorescence (ROS production) at
increasing timepoints. (a, b, c) Time course of ROS production (ﬂuorescence) 7.5μg/mL, 15μg/mL and 30μg/mL cholesterol, respectively.
(d, e, f) area under curve analysis (Prism) 7.5μg/mL, 15μg/mL and 30μg/mL cholesterol respectively. n = 5 monocyte isolations. ∗P<0.05,
∗∗P<0.01, ∗∗∗P<0.001 paired t-test.
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Figure 3: MCP-1 production by human primary blood monocytes after incubation with native, oxidised, or probucol-treated CRLPs.
Monocytes were incubated with CRLPs, oxCRLPs or pCRLPs (a) 15μg/mL cholesterol; (b) 30μg/mL cholesterol) for 24h at 37◦C. After
this time cells were pelleted and the supernatants were collected for analysis by ELISA. n = 3 monocyte isolations. ∗P<0.05 compared to
control, #P<0.05 compared to pCRLPs-treated monocytes. One-way ANOVA with Bonferroni’s posttest.6 International Journal of Vascular Medicine
oxCRLPs behaved in a similar manner to CRLP. Thus, prior
todiﬀerentiationofmonocytesintomacrophages,changesin
the oxidative state of CRLP have eﬀects on intracellular lipid
accumulation which more closely resemble those seen with
LDL. This diﬀerence may be due to the receptor-mediated
mechanisms used by the cells to take up the particles. Our
previous work has suggested that the enhanced uptake of
probucol-containing CRLPs by THP-1 macrophages is due
to increased uptake via the LDL-receptor-related protein-1
[22]; however, the expression of this protein has been found
to be low in monocytes and induced only on diﬀerentiation
intomacrophages[43].Thus,reducedexpressionofLRP-1in
monocytes may account for both the lower uptake of pCRLP
as compared to CRLP in these cells and for the diﬀering
eﬀects of the presence of probucol on uptake of the particles
in monocytes as compared to macrophages.
R O Sp r o d u c t i o ni ss t i m u l a t e di nm o n o c y t e sa sad e f e n c e
against infection and during other inﬂammatory reactions
[3–5]. Human monocytes have been reported to generate
ROS when exposed to oxidised LDL [44], and CMRs have
been found to increase ROS production in THP-1 cells [30].
In agreement with our earlier study [30], CRLP treatment of
monocytes caused rapid and prolonged generation of ROS
(Figure 2). Although this eﬀect was not enhanced when the
particles were oxidized, it was abolished completely when
pCRLPs were used. These results suggest that the presence
of antioxidant in CMRs inhibits their induction of monocyte
ROS production.
Human peripheral blood monocytes are known to
increase the secretion of MCP-1 in response to inﬂammation
[4]. We have found previously, however, that CRLP cause a
marked decrease in MCP-1 secretion by human monocytes
[30], and we have also demonstrated similar eﬀects in
macrophages using HMDMs and THP-1 cells [21, 22].
EvaluationoftheeﬀectsoftheoxidativestateoftheCRLPsin
macrophages showed that oxCRLPs caused a similar reduc-
tion to that observed with CRLPs, but, when the particles
were protected from oxidation with probucol, the eﬀect was
signiﬁcantly reduced [22]. The results of the present study
indicate that monocytes behave like macrophages in the
response of MCP-1 secretion to changes in the oxidative state
of CRLP, with oxCRLP and CRLP decreasing production
to a similar extent, while the incorporation of antioxidant
into the particles abolishes the eﬀect (Figure 3). However,
in our earlier monocyte study [30], we demonstrated that a
decrease in medium concentrations of MCP-1 after exposure
of monocytes to CRLP increased cell migration towards a
higherconcentrationofthechemokine.Thisﬁndingsuggests
that CMR may cause an increase in the chemotactic gradient
ofMCP-1acrosstheendotheliumbecauseofreducedMCP-1
secretion by monocytes in the blood vessel lumen mi-
croenvironment thus having a promigratory eﬀect on cir-
culating monocytes. Our present results, therefore, suggest
that the presence of antioxidants in CMR may decrease their
propensity to enhance monocyte chemotaxis.
Previous studies with oxLDL have demonstrated that its
oxidative state is important for the reported proinﬂamma-
tory,proatherogeniceﬀectsinmacrophages[5,26,45].Inter-
estingly, although clinical trials with dietary supplementa-
tion of antioxidants have proved disappointing, [46] in vitro
antioxidants have shown eﬃcacy. Treatment of endothelial
cells with the antioxidant ﬂavonoid, luteolin, protects them
from the eﬀects of oxLDL eﬀects by downregulation of the
lectin-like oxidised LDL receptor [47]. Similarly, the citrus-
derived ﬂavonoid nobiletin has recently been reported to
inhibit monocyte to macrophage diﬀerentiation and scav-
enger receptor activity in THP-1 cells via inhibition of PKC
[48]. Although we cannot completely rule out the pos-
sibility that the eﬀects observed in the present work are
speciﬁcally due to the presence of probucol, rather than
protectionoftheparticlesfromoxidation,ourpreviouswork
with macrophages showing that probucol and lycopene, a
chemically unrelated antioxidant, have remarkably similar
eﬀects on lipid accumulation suggest that this is not the
case. Thus, the present work provides evidence to suggest
that antioxidants from the diet carried in CMR may help to
protect against the eﬀects of these lipoproteins in promoting
the activation of human primary monocytes, but further
studies are required to substantiate this conclusion.
Previous work in our laboratory has shown that down-
regulation of NF-κB activation is involved in the inhibition
of proinﬂammatory cytokines secretion by CRLPs [21].
It seems likely, therefore, that NF-κB is involved in the
modulation of monocyte activation by CMRs, and this is
supportedbytheﬁndingfromourpreviousstudythatCRLP-
stimulated monocyte ROS production is mediated via NF-
κB[ 30]. Thus, there may be early activation of this pathway
followed by later inhibition of de novo NF-κB synthesis,
leadingtodownregulationofconstitutiveMCP-1expression.
4. Conclusions
This study demonstrates that the changes in the oxidative
state of CRLP inﬂuence their eﬀects on peripheral blood
monocytes. Thus, protection of the particles by the incorpo-
ration of the antioxidant probucol decreases the induction of
lipidaccumulationandROSproductioninthecellsobserved
with CRLP and oxCRLP but abolishes the suppressive eﬀect
on MCP-1 secretion. The results support the hypothesis that
CMRplayaroleintheincreaseinmonocyteactivationwhich
contributes to early atherosclerotic lesion formation and
suggest that dietary antioxidants carried in CMR may reduce
orpreventsomeofthepotentiallyinﬂammatoryeﬀectsofthe
lipoproteins on these cells.
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